ClinicalTrials.govpublic full text
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
diabetes mellitus, type 2, endothelial glycocalyx integrity, oxidative stress biomarkers, arterial stiffness, gls, nt-probnp, gdf-15, mots-c, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876261
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.